Enterprise Value
-12.9M
Cash
25.79M
Avg Qtr Burn
-3.069M
Short % of Float
2.67%
Insider Ownership
2.82%
Institutional Own.
11.10%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
LPCN 1144 Details Non-alcoholic steatohepatitis | Phase 3 Update | |
LPCN 1107 Details Preterm birth | Phase 3 Update | |
Brexanolone (LPCN 1154) Details Postpartum depression | Phase 3 Initiation | |
LPCN 1148 Details Cirrhosis | Phase 2 Update |